Drug‐induced liver injury by glatiramer acetate leading to liver transplant: A case report

Abstract

Abstract Glatiramer acetate (GA) is a widely used immune‐modulating drug in relapsing multiple sclerosis (MS). Although a few cases of drug‐induced liver injury during GA therapy have been reported earlier, herein we present the case of a 43‐year‐old woman with relapsing MS who experienced acute liver failure after GA therapy, ultimately leading to liver transplant.

Keywords

• drug‐induced liver injury
• glatiramer acetate
• liver failure
• liver transplantation
• multiple sclerosis